- MBBS – SMIMER, Veer Narmad South Gujarat University, Surat (2003–2009)
- MD (Radiation Oncology) – S.P. Medical College- Bikaner, Rajasthan University of Health Sciences-Jaipur (2010–2013)
- DrNB (Medical Oncology) – HCG-Aastha Cancer Centre, Ahmedabad (2022–2025)
- He completed his super speciality training - DrNB Medical Oncology from HCG Aastha cancer center and trained and actively involved in patient management, academic discussions, and multidisciplinary oncology care, including cancer screening, preventive oncology, cancer diagnosis, management and follow up. He is experienced with managing solid tumors and hematological malignancies with systemic anti neoplastic therapies like chemotherapy, hormonal therapy, Immunotherapy, biological therapies like BiTe, ADC etc. as well cancer vaccine and Autologous stem cell transplant.
- He completed his specialty training in MD Radiotherapy from SP Medical college- Acharya Tulsi Regional Cancer Center and research institute, Bikaner and trained and skilled in management of solid tumors with conventional and conformal radiotherapy like 3DCRT, IMRT, VMAT, IGRT, adaptive radiotherapy and brachytherapy. He practiced as a consultant radiation oncologist at various institutions like Lions cancer detection cancer centre-surat, HCG-NCHRI-Nagpur, HCG hospital-bhavnagar and practiced infield of oncology with advanced conformal radiation therapies like IGRT, VMAT, SRT, SRS & image guided adaptive brachytherapies.
- Best Orator at TYSA-ICON competition, March 2023
- 2nd Runner-Up in National Quiz TYSA-ICON, March 202
- First prize quiz winner at HCG breast and GI midcon, Sept 2022
- Presented various research papers in form of abstract and poster presentation at various national and international conferences like ISMPO, 3rd ICC, FHNOcon and ESMO ASIA.
Dr. Hirapara has actively participated in numerous state, national, and international conferences, reflecting his ongoing pursuit of excellence and learning:
- ICON
- ESMO Asia
- Various academic forums and oncology updates
- ASCO, ESMO, ISMPO
- AROI, ISNO, IBS, IMA
- Actively associated with national and international oncology communities through academic conferences and educational networks
- Brain tumors
- Head & Neck Cancers
- Lung Cancer
- Urothelial tumors
- Hematoid malignancy - Lymphoma & Myeloma
.svg)
